dc.contributor.author | Sadigh-Eteghad, S | |
dc.contributor.author | Majdi, A | |
dc.contributor.author | Talebi, M | |
dc.contributor.author | Mahmoudi, J | |
dc.contributor.author | Babri, S | |
dc.date.accessioned | 2018-08-26T07:43:12Z | |
dc.date.available | 2018-08-26T07:43:12Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47959 | |
dc.description.abstract | Nicotinic acetylcholine receptors (nAChRs) seem to play an integral role in the progress and/or prevention of Alzheimer's diseases (AD). Functional abnormalities and problems in biogenesis and trafficking of nAChRs are two major culprits in AD; on the other hand, chaperones modulate post-translational changes in nAChRs. Moreover, they indirectly regulate nAChRs by controlling AD-related proteins such as tau and amyloid beta (A beta). In this review, we go through recent studies which are showing that chaperones modulate the expression of nAChRs in a subtype-specific manner and explain how AD progress is affected by nAChRs chaperoning. (C) 2015 Elsevier B.V. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | EUROPEAN JOURNAL OF PHARMACOLOGY | |
dc.subject | Regulation | |
dc.subject | Nicotinic acetylcholine receptors | |
dc.subject | Alzheimer | |
dc.subject | Chaperone | |
dc.title | Regulation of nicotinic acetylcholine receptors in Alzheimer's disease: A possible role of chaperones | |
dc.type | Review | |
dc.citation.volume | 755 | |
dc.citation.spage | 34 | |
dc.citation.epage | 41 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1016/j.ejphar.2015.02.047 | |